Medicinal Genomics

Going forward, the company will focus on its wholly owned subsidiary Medicinal Genomics Corporation, which conducts cannabis genetics research.

The SBIR Phase 1 award will go toward developing a test using immuno-PCR technology to detect toxins in medical marijuana. 

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Courtagen Life Sciences today said that it has acquired Medicinal Genomics, a Marblehead, Mass.-based firm that has sequenced the genome of Cannabis sativa and Cannabis indica.

By Julia Karow
This article, originally published Jan. 17, has been updated with additional information from Courtagen.

Genetic cancer researcher Constance Griffin has passed away from pancreatic cancer.

Paired Ends

Premium

Kevin McKernan has founded Medicinal Genomics and is also now serving as its CEO. Most recently, he was the head of R&D for Ion Torrent at Life Technologies.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.